Orphan Synergy Europe - Pharma Aktie
| 8,87EUR | 0,01EUR | 0,11% |
WKN DE: A14QXP / ISIN: FR0012127173
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 75,15 |
| Emile Loria | 12,14 |
| Dominique Constantini | 9,20 |
| Alexis Peyroles | 4,26 |
| Maryvonne Hiance | 1,94 |
| Nicolas Poirier, PhD | 1,57 |
| Mandarine Funds - Europe Micro Cap | 1,05 |
| BSO Bio Santé | 0,55 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 42 | 51 | 61 | 67 | 55 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,62 | 0,20 | 0,43 | 0,27 | 0,04 |
Bilanz (in Mio. EUR) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 33 | 40 | 44 | 37 | 30 |
| Summe Anlagevermögen | 56 | 57 | 57 | 54 | 51 |
| Summe Aktiva | 89 | 97 | 102 | 92 | 82 |
Bilanz (in Mio. EUR) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 11 | 20 | 37 | 45 | 46 |
| Summe Fremdkapital | 30 | 36 | 54 | 59 | 59 |
| Summe Eigenkapital | 58 | 61 | 48 | 33 | 23 |
| Summe Passiva | 89 | 97 | 102 | 92 | 82 |
Adresse
| 22, Boulevard Benoni Goullin, 44000 Nantes | |
| Telefon | +33 (2) 28-29-10-10 |
| Internet | http://www.ose-immuno.com |
Management
|
Anne-Laure Autret-Cornet
Director, Chief Financial & Administrative Officer |
|
Brigitte Dreno
Independent Director |
|
Cécile Nguyen-Cluzel
Independent Director |
|
Didier Hoch
Chairman |
|
Dominique Costantini
Chief Development & Strategy |
|
Eric Jean Marie Leire
Independent Director |
|
Jean Jacques Mention
Chief Business Officer |
|
Jean-Pascal Conduzorgues
Chief Manufacturing Officer |
|
Laurence de Schoulepnikoff
Chief Operating & Business Officer |
|
Linda Lebon
Chief Regulatory Officer |
|
Marc Dechamps
Independent Director |
|
Markus Goebel
Independent Director |
|
Martine Ortin George
Independent Director |
|
Maryvonne Hiance
Vice Chairman & Public Affairs Director |
|
Nicolas Poirier
Chief Executive Officer & Director |
|
Silvia Comis
Head-Clinical Development |
|
Thomas Guillot
Investor Relations Contact |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
